Latest 10-Q quarterly reports

McKesson Corporation's Q1 2027 results show an 8% increase in revenue to $105.4 billion, driven by strong performance in its North American Pharmaceutical and Oncology & Multispecialty segments, despite a dip in diluted EPS.

Wheels Up Experience Inc. reported a net loss of $107.2 million for Q2 2026, with revenue down 4% year-over-year, while also highlighting fleet modernization and cost-saving initiatives.

W&T Offshore's Q2 2026 filing shows a significant increase in total revenues to $162.6 million and a decrease in total operating expenses to $139.9 million, driven by higher oil prices and production volumes, alongside successful cost reduction initiatives.

Solventum Corporation's Q2 2026 Form 10-Q filing details stable revenue growth, strategic portfolio optimization, and ongoing cost-saving programs, alongside significant legal provisions and restructuring charges.

Upstart Holdings, Inc. filed an amendment to its Q2 2026 Form 10-Q, primarily to correct a typographical error in risk factors, while reporting significant revenue growth driven by increased loan originations.

Everspin Technologies announced a 41.9% increase in total revenue for the second quarter of 2026, driven by robust product sales, despite a significant rise in general and administrative expenses due to litigation costs.

Palomar Holdings, Inc. announced significant increases in gross written premiums and net income for the second quarter of 2026, driven by growth across multiple product lines.

Social Commerce Partners Corporation reports on its financial condition for the quarter ended June 30, 2026, highlighting its status as a blank check company focused on a future business combination.

Vir Biotechnology, Inc. announced its Q2 2026 financial results, highlighting a substantial upfront payment from a new collaboration with Astellas, alongside progress in its clinical pipeline.

JBT Marel Corporation announced a significant increase in net income and Adjusted EBITDA for the second quarter of 2026, driven by revenue growth and improved margins, despite ongoing integration costs.

National Bank Holdings Corporation reported a 25.3% increase in total deposits and a 31.5% rise in total loans for the six months ended June 30, 2026, driven by the Vista acquisition.

Encore Capital Group, Inc. announced robust financial results for the second quarter of 2026, showcasing significant revenue increases and improved net income, alongside strategic debt management.

Nine Energy Service, Inc. filed its Q2 2026 10-Q, detailing a net loss of $4.9 million and continued operational challenges following its emergence from bankruptcy.

Zevra Therapeutics announced a substantial increase in revenue for the second quarter of 2026, driven by MIPLYFFA sales and expanded access programs, while also detailing debt repayment and ongoing clinical trial progress.

Talen Energy Corporation's Q2 2026 Form 10-Q reveals a net loss of $92 million, driven by increased operating expenses and interest costs, alongside strategic acquisition activity and debt refinancing.

Griffon Corporation's Q3 2026 Form 10-Q filing details revenue growth driven by pricing and mix, successful divestitures of non-core assets, and a focus on its core building products business.

FuboTV Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing revenue growth driven by the Hulu Live Business integration, but also highlighting ongoing operating losses and a substantial debt load.

Redwood Trust's Q2 2026 filing shows robust mortgage banking activity, with production nearly doubling year-over-year, though legacy investments continue to weigh on overall results.

ADMA Biologics announced a 2.0% increase in total revenues for Q2 2026, driven by significant ASCENIV sales growth, alongside improved gross margins.

Verra Mobility Corporation's Q2 2026 Form 10-Q reveals a net loss driven by substantial goodwill and intangible asset impairments, alongside revenue growth and ongoing contract negotiations.

Coherus Oncology's Q2 2026 Form 10-Q reveals continued operational losses and a significant decrease in cash reserves, though LOQTORZI sales show growth.

ZoomInfo Technologies Inc. reported its second-quarter 2026 financial results, highlighting a substantial $650.5 million goodwill impairment charge and a net loss, alongside modest revenue growth.

The Hackett Group reported a decrease in revenue for the second quarter and first six months of 2026 compared to the prior year, but demonstrated improved operating income through cost efficiencies and a strategic focus on Gen AI.

Array Technologies reported a 6% year-over-year revenue decrease for Q2 2026, driven by a significant drop in its international STI Operations segment, though gross profit saw a modest increase.

SecureTech Innovations, Inc. has amended its Q3 2025 10-Q filing to restate prior financial statements due to accounting errors and disclosed material weaknesses in internal controls, raising substantial doubt about its ability to continue as a going concern.

SecureTech Innovations, Inc. has amended its Q2 2025 10-Q filing to restate prior financial statements due to accounting errors and disclosed material weaknesses in internal controls, raising going concern doubts.

Stoneridge, Inc. reported a net loss for the second quarter of 2026, with revenues increasing but gross margins declining due to higher material costs and adverse foreign currency impacts.

Cytek Biosciences announced a 6% increase in total revenue for both the three and six-month periods ending June 30, 2026, reaching $48.1 million and $92.3 million respectively, though net losses also widened.

International Paper reported a net loss of $12 million for the second quarter of 2026, with net sales decreasing to $6 billion compared to the prior year.

EverCommerce Inc. announced its Q2 2026 results, showcasing revenue growth and improved operating income, while also detailing strategic investments and ongoing efforts to remediate internal control weaknesses.